Amit Gruber

Haifa, HA, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Recellularized Humanized Bioengineered Biatrial Model for Arrhythmia, Biological Pacemakers, and Optogenetic Studies.

Recellularized Humanized Bioengineered Biatrial Model for Arrhythmia, Biological Pacemakers, and Optogenetic Studies.

Journal: Circulation research
Published: March 23, 2026

Kidney function and acid-base status as gatekeepers of natriuretic and diuretic responsiveness in chronic HF: insights from the DEA-HF clinical trial.

Kidney function and acid-base status as gatekeepers of natriuretic and diuretic responsiveness in chronic HF: insights from the DEA-HF clinical trial.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: January 04, 2026

Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA-HF trial.

Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA-HF trial.

Journal: ESC heart failure
Published: February 13, 2025

Modeling Heart Failure With Preserved Ejection Fraction Using Human Induced Pluripotent Stem Cell-Derived Cardiac Organoids.

Modeling Heart Failure With Preserved Ejection Fraction Using Human Induced Pluripotent Stem Cell-Derived Cardiac Organoids.

Journal: Circulation. Heart failure
Published: January 28, 2025

Reply: Choosing the Appropriate Combination of Diuretics for Patients With Heart Failure and Congestion.

Reply: Choosing the Appropriate Combination of Diuretics for Patients With Heart Failure and Congestion.

Journal: JACC. Heart failure
Published: October 02, 2024

Diuresis Efficacy in Ambulatory Congested Heart Failure Patients: Intrapatient Comparison of 3 Diuretic Regimens (DEA-HF).

Diuresis Efficacy in Ambulatory Congested Heart Failure Patients: Intrapatient Comparison of 3 Diuretic Regimens (DEA-HF).

Journal: JACC. Heart failure
Published: December 31, 2023

Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.

Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.

Journal: Journal of the American Heart Association
Published: February 03, 2022

Synthetic cells with self-activating optogenetic proteins communicate with natural cells.

Synthetic cells with self-activating optogenetic proteins communicate with natural cells.

Journal: Nature communications
Published: June 17, 2021

Literature Review and Knowledge Distribution During an Outbreak: A Methodology for Managing Infodemics.

Literature Review and Knowledge Distribution During an Outbreak: A Methodology for Managing Infodemics.

Journal: Academic medicine : journal of the Association of American Medical Colleges
Published: March 31, 2021

Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.

Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.

Journal: JCI insight
Published: January 07, 2021

Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes.

Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes.

Journal: Nature communications
Published: September 10, 2018

Optogenetic Neuromodulation of the Heart.

Optogenetic Neuromodulation of the Heart.

Journal: Journal of the American College of Cardiology
Published: September 30, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026